What’s New in Breast Cancer: Trials, Approvals, and What Advocates Should Know

Dr. Sara Hurvitz shares insights on recent developments and FDA approvals.

Your gift is doubled through December 31.

Donate Now
Date
January 22, 2027
Time
1:00 PM

Learn about the most important recent developments in breast cancer trials and FDA approvals.

Dr. Sara Hurvitz will share insights into key findings and discuss what the new evidence means for patients, caregivers, and clinical practice. The presentation will be followed by a moderated discussion and audience Q&A.

Speakers

Dr. Sara Hurvitz, MD, FACP
Fred Hutch Cancer Center